Sign up to save your podcasts
Or
Share Idaho Matters Doctors Roundtable: September 20, 2023
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Idaho Matters Doctors Roundtable: September 20, 2023
A generic of EpiPen, an epinephrine injection auto-injector, used for allergic reactions.(Tony Webster / Flickr)
In a surprise move yesterday the FDA put the brakes on a new drug that was supposed to take the place of EpiPen's to treat anaphylactic shock. And a nasty new virus is making the rounds in India.
Dr. David Pate, former CEO of St. Luke's Health System, joined Idaho Matters to talk more.
View all episodes
By Boise State Public Radio
4.5
102102 ratings
A generic of EpiPen, an epinephrine injection auto-injector, used for allergic reactions.(Tony Webster / Flickr)
In a surprise move yesterday the FDA put the brakes on a new drug that was supposed to take the place of EpiPen's to treat anaphylactic shock. And a nasty new virus is making the rounds in India.
Dr. David Pate, former CEO of St. Luke's Health System, joined Idaho Matters to talk more.
More shows like Idaho Matters
View all
This American Life
90,937 Listeners
Radiolab
44,032 Listeners
Fresh Air
38,567 Listeners
Hidden Brain
43,606 Listeners
Wait Wait... Don't Tell Me!
38,822 Listeners
On the Media
9,259 Listeners
On Point with Meghna Chakrabarti
3,978 Listeners
Reveal
8,477 Listeners
Science Vs
12,153 Listeners
Science Friday
6,472 Listeners
1A
4,674 Listeners
Throughline
16,457 Listeners
Idaho Reports
12 Listeners
Extremely American
435 Listeners
The Connector: Idaho Daily News
10 Listeners